Clinical trial Recruiting at 2 sites Interventional Ages 50 to 99

Aromatherapy for Mild Cognitive Impairment and Mild Dementia

Official title: Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia (SENSE)

Run by National Cancer Centre, Singapore · NCT07234357 · Data updated 2026-11-12

This study tests whether a diffused essential-oil blend for 6 months can help reduce symptoms for people with MCI or mild dementia and lessen caregiver stress.

Quick facts

Study typeInterventional
Ages50 Years to 99 Years
SexAll
Enrollment200 (estimated)
SponsorNational Cancer Centre, Singapore
Academic / other
Locations2 sites (Singapore and 1 other locations)
StatusRecruiting
StartedJune 9, 2026
Main results expectedNovember 2027
Study endsNovember 2027
Registry record updatedJuly 17, 2026
Trial IDNCT07234357 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 50+, diagnosed with MCI or mild dementia, and with a willing, capable caregiver who languages match the site.

Probably not a fit

Patients who do not tolerate or comply with the aromatherapy regimen or have conditions conflicting with essential oils may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

SENSE is a non-blinded, interventional study enrolling about 200 patient–caregiver pairs from Singapore. Participants are randomized to receive either standard care or an aromatherapy package including a diffuser, a proprietary essential oil blend, and a diary, with guidance to diff use twice daily for at least 5 minutes. Caregivers and patients complete cognitive and behavioral assessments at baseline, 12 weeks, and 24 weeks, and caregivers are monitored for burden and mood. The study aims to gauge long-term adherence and safety of supervised aromatherapy in this population.

Why it matters

Potential benefit: If successful, patients may experience improvements in cognitive or behavioral symptoms and caregivers may experience reduced burden.

How similar studies have gone: Previous aromatherapy studies suggest potential symptom relief, but results are mixed; this trial adds structured caregiver involvement and long-term follow-up.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For patients:

* Aged 50 years old and above.
* Confirmed diagnosis of MCI or mild dementia based on clinical records.
* Has one identified caregiver aged 21 years and above who is willing to provide written informed consent for his/her own participation; is able to read, understand, and speak the designated language at the study site; either lives with the subject or sees the subject for ≥2 hours/day ≥3 days/week; agrees to accompany the subject to each study visit; and is able to verify daily compliance with study intervention.

For caregivers:

* Aged 21 years old and above.
* Willing and able to provide written informed consent
* Identified as the caregiver for recruited patient in this study can read, understand, and speak the designated language at the study site; either lives with the recruited patients or sees the patient for ≥2 hours/day ≥3 days/week.
* Agrees to accompany the patient to each study visit; and can verify daily compliance with study intervention.

Exclusion Criteria:

For patients:

* Olfactory impaired/dysfunctional.
* Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations.
* Has Reactive Airway Disease (e.g, Asthma).
* Participant without a caregiver.
* Pregnant, breastfeeding, or intending to conceive during study period.

For caregivers:

* Physically or mentally incapable of providing verbal / written consent
* Does not have regular or meaningful contact with the participant (e.g. less than 2 hours/day or less than 3 days/week).
* Not able to follow patient to each study visit.

Where it's running

  • National Cancer Centre Singapore
    Singapore, Singapore
    Recruiting
  • Sengkang General Hospital
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.